** GlaxoSmithKline second biggest FTSE 100 faller, down 3.4 pct, as analysts downgrade near-term estimatesafter drugmaker warns of "high teens" percentage fall in 2015EPS
** Brokerages Bernstein and Bryan Garnier both cut pricetargets. Bernstein analyst Tim Anderson says 2015 guidance "muchworse than our modeling of -5 pct or consensus of -11 pct"
** GSK argued at May 6 investor day it was taking short-termhit in 2015, but expected long-term gain as it reshapes businessto ensure reliable growth and secure dividend
(RM: ben.hirschler.thomsonreuters.com@reuters.net)